Evidence map›Paper›PMID 31161306›Full record

ReviewCurrent psychiatry reports2019

HIV, Drug Injection, and Harm Reduction Trends in Eastern Europe and Central Asia: Implications for International and Domestic Policy.

Katherine LaMonaca, Kostyantyn Dumchev, Sergii Dvoriak, Lyuba Azbel, Olga Morozova, Frederick L Altice

Open access · greenAbstract readReview
In one paragraph

Review in Current psychiatry reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

Katherine LaMonacaDepartment of Medicine, Section of Infectious Diseases, AIDS Program, Yale University School of Medicine, 135 College Street Suite 323, New Haven, CT, 06510, USA.
Kostyantyn DumchevUkrainian Institute on Public Health Policy, Kyiv, Ukraine.
Sergii DvoriakAcademy of Labour, Social Relations and Tourism, Kyiv, Ukraine.
Lyuba AzbelLondon School of Hygiene & Tropical Medicine, London, UK.
Olga MorozovaDepartment of Biostatistics, Yale University School of Public Health, New Haven, CT, USA.
Frederick L AlticeDepartment of Medicine, Section of Infectious Diseases, AIDS Program, Yale University School of Medicine, 135 College Street Suite 323, New Haven, CT, 06510, USA. Frederick.Altice@yale.edu.
Yale University · USAcademy of Labour Social Relations and Tourism · UALondon School of Hygiene & Tropical Medicine · GBUkrainian Institute of Public Health Policy · UA

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Research Mentoring and Building Capacity of underrepresented Minority Research Scientists in India.D43TW010540 · FIC · YALE UNIVERSITY · PI MICHELE BARRY, Eva Harris · 2017 to 2026
$15.5M
Prison Interventions and HIV Prevention CollaborationR01DA029910 · NIDA · YALE UNIVERSITY · PI FREDERICK LEWIS ALTICE · 2010 to 2026
$7.9M
Enhancing Health Outcomes Among HIV+ Substance AbusersK24DA017072 · NIDA · YALE UNIVERSITY · PI ALTICE, FREDERICK LEWIS · 2003 to 2012
$1.5M
Prisons, Drug Injection and the HIV Risk EnvironmentR21DA042702 · NIDA · YALE UNIVERSITY · PI MEYER, JAIMIE · 2017 to 2018
$358k
Optimizing Medication-Assisted Therapy for Opioid Dependence in Ukraine: HIV Impact Modeling and Cost-Effectiveness EvaluationR36DA042643 · NIDA · YALE UNIVERSITY · PI MOROZOVA, OLGA · 2016 to 2017
$98k
FIC NIH HHS D43 TW010540NCATS NIH HHS UL1 TR001863NIDA NIH HHS K24 DA017072NIDA NIH HHS R01 DA029910NIDA NIH HHS R21 DA042702NIDA NIH HHS R36 DA042643
6 · The paper itself

Abstract

purpose of reviewScaling up evidence-based HIV prevention strategies like opioid agonist therapies (OAT), syringe services programs (SSPs), and antiretroviral therapy (ART) to mitigate the harms of drug injection is crucial within Eastern Europe and Central Asia (EECA), the only region globally where HIV incidence and mortality are increasing. RECENT

findingsThough the proportion of new HIV cases directly attributable to drug injection has recently declined, it remains a critical driver of HIV, especially to sexual partners. Concurrently, scale-up of OAT, SSPs, and ART has remained low, contributing to a volatile HIV epidemic among people who inject drugs (PWID). Despite evidence that drug injection contributes to an evolving HIV epidemic in EECA, coverage of evidence-based harm reduction programs remains substantially below needed targets. Due to a combination of punitive drug laws, ideological resistance to OAT among clinicians and policymakers, and inadequate domestic and international funding, limited progress has been observed in increasing the availability of these programs.

Indexed as

Harm ReductionHealth PolicyAnti-HIV AgentsAsiaEurope, EasternHIV InfectionsHumansNarcotic AntagonistsNeedle-Exchange ProgramsSubstance Abuse, IntravenousAnti-HIV AgentsNarcotic AntagonistsCentral AsiaDrug injectionEastern EuropeHarm reductionHIV preventionOpioid agonist therapy

Identifiers

PMID31161306
PMCPMC6685549
OpenAlexW2948087851

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.